InsiderTrades.com logo
⭕ [URGENT] Buy Alert just triggered
From Behind the Markets   |   Ad
My absolute favorite stock just hit a critical "buy now" trigger price.
Click here for the ticker >>>

CHRO Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $17,210.00
Insider Selling (Last 12 Months): $0.00

Chromocell Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Chromocell Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Chromocell Therapeutics Share Price & Price History

Current Price: $0.87
Price Change: ▼ Price Decrease of -0.04 (-4.39%)
As of 09/18/2024 01:00 AM ET

This chart shows the closing price history over time for CHRO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
⭕ [URGENT] Buy Alert just triggered
From Behind the Markets   |   Ad
My absolute favorite stock just hit a critical "buy now" trigger price.
Click here for the ticker >>>

Chromocell Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2024Knuettel Francis IICEOBuy1,700$0.97$1,649.00544,210View SEC Filing Icon  
9/12/2024Richard MalamutDirectorBuy10,400$0.94$9,776.0091,565View SEC Filing Icon  
9/10/2024Knuettel Francis IICEOBuy6,500$0.89$5,785.00537,010View SEC Filing Icon  
See Full Table
Crypto ‘Banana Zone’ Incoming…
From Crypto 101 Media   |   Ad
What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the 'Banana Zone' in the crypto market… A rare but explosive market that we've seen just three times in history… Until now!
Click here to download my full report, The Crypto Bull Run Millionaire Blueprint NOW.

SEC Filings (Institutional Ownership Changes) for Chromocell Therapeutics (NYSE:CHRO)

77.96% of Chromocell Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Chromocell Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2024Anson Funds Management LP251,888$0.66M0.0%N/A4.284%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Read More on Chromocell Therapeutics

Today's Range

Now: $0.87
Low: $0.87
High: $0.94

50 Day Range

MA: $0.96
Low: $0.68
High: $1.46

52 Week Range

Now: $0.87
Low: $0.59
High: $6.00

Volume

10,391 shs

Average Volume

23,620 shs

Market Capitalization

$5.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Chromocell Therapeutics?

Chromocell Therapeutics' top insider shareholders include:
  1. Knuettel Francis II (CEO)
  2. Richard Malamut (Director)
Learn More about top insider investors at Chromocell Therapeutics.
⭕ [URGENT] Buy Alert just triggered
From Behind the Markets   |   Ad
My absolute favorite stock just hit a critical "buy now" trigger price.
Click here for the ticker >>>